JOHNSON&JOHNSON ($JNJ)
Filing Information
| Accession Number | 0000200406-26-000175 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 18, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
45,000
Total Value
$5,685,450.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, WWC. Innovative Medicine | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 15,000 | $115.67 | $1,735,050.00 | 209,451 | Direct | โ | View Details | |
EVP, WWC. Innovative Medicine | Common Stock | โ | Aug 17, 2026 | Sale | 15,000 | $263.36 | $3,950,400.00 | 194,451 | Direct | โ | View Details | |
EVP, WWC. Innovative Medicine | Employee Stock Options (Right to Buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 28,712 | Direct | โ | View Details |